This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Light Sciences Oncology (light-activated cancer drug therapy) raised $40.1mm through a Series C private placement to undisclosed investors. The company is planning to use the proceeds to continue development of its Litx (Light Infusion Therapy) candidate, which is in Phase III for hepatocellular carcinoma and metastatic colorectal cancer. Other Phase III trials are also set for brain cancer, as well as Phase I/II studies for benign prostatic hyperplasia.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?